These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30716317)

  • 1. Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension.
    Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Ismail NM
    Eur J Pharmacol; 2019 May; 850():75-87. PubMed ID: 30716317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pressure lowering effect and structure-activity relationship of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds in ocular normotensive rats: Insight on possible link with hypotensive activity.
    Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Johari B; Mohd Ismail N
    Eur J Pharm Sci; 2018 Mar; 114():245-254. PubMed ID: 29274441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical trans-resveratrol ameliorates steroid-induced anterior and posterior segment changes in rats.
    Razali N; Agarwal R; Agarwal P; Tripathy M; Kapitonova MY; Kutty MK; Smirnov A; Khalid Z; Ismail NM
    Exp Eye Res; 2016 Feb; 143():9-16. PubMed ID: 26424219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs.
    Razali N; Agarwal R; Agarwal P; Kapitonova MY; Kannan Kutty M; Smirnov A; Salmah Bakar N; Ismail NM
    Eur J Pharmacol; 2015 Feb; 749():73-80. PubMed ID: 25481859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension.
    Razali N; Agarwal R; Agarwal P; Kumar S; Tripathy M; Vasudevan S; Crowston JG; Ismail NM
    Clin Exp Ophthalmol; 2015; 43(1):54-66. PubMed ID: 24995479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data on the effects of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds on intraocular pressure of ocular normotensive rats.
    Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Mohd Ismail N
    Data Brief; 2018 Jun; 18():523-554. PubMed ID: 29896529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.
    Van de Velde S; Van Bergen T; Sijnave D; Hollanders K; Castermans K; Defert O; Leysen D; Vandewalle E; Moons L; Stalmans I
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1006-16. PubMed ID: 24474276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IOP lowering effect of topical trans-resveratrol involves adenosine receptors and TGF-β2 signaling pathways.
    Razali N; Agarwal R; Agarwal P; Froemming GRA; Tripathy M; Ismail NM
    Eur J Pharmacol; 2018 Nov; 838():1-10. PubMed ID: 30171854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model.
    Wang F; Ma F; Song Y; Li N; Li X; Pang Y; Hu P; Shao A; Deng C; Zhang X
    Eur J Pharmacol; 2020 Oct; 884():173369. PubMed ID: 32712092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Histamine H₃ Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma.
    Lanzi C; Lucarini L; Durante M; Sgambellone S; Pini A; Catarinicchia S; Łażewska D; Kieć-Kononowicz K; Stark H; Masini E
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical ocular dexamethasone decreases intraocular pressure and body weight in rats.
    Sato K; Nishiguchi KM; Maruyama K; Moritoh S; Fujita K; Ikuta Y; Kasai H; Nakazawa T
    J Negat Results Biomed; 2016 Mar; 15():5. PubMed ID: 26971048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
    Abbhi V; Saini L; Mishra S; Sethi G; Kumar AP; Piplani P
    Bioorg Med Chem; 2017 Nov; 25(21):6071-6085. PubMed ID: 29033348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury.
    Shaw PX; Sang A; Wang Y; Ho D; Douglas C; Dia L; Goldberg JL
    Exp Eye Res; 2017 May; 158():33-42. PubMed ID: 27443501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.
    Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B
    Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension.
    Roddy GW; Chowdhury UR; Monson KJ; Fautsch MP
    Curr Eye Res; 2021 Oct; 46(10):1525-1530. PubMed ID: 33757401
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes.
    Nishio M; Fukunaga T; Sugimoto M; Ikesugi K; Sumi K; Hidaka H; Uji Y
    Curr Eye Res; 2009 Apr; 34(4):282-6. PubMed ID: 19373576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant effect of gallic acid on retinal ganglion cells in glaucoma model.
    Jiang R; Lv Y; Chen B; Wu X; Zou Y; Liang L
    Sci Rep; 2024 Jun; 14(1):14907. PubMed ID: 38942959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model.
    Hong S; Kim CY; Lee WS; Shim J; Yeom HY; Seong GJ
    Exp Eye Res; 2010 Jan; 90(1):97-103. PubMed ID: 19782071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure-lowering activity in rodent eyes.
    Stankowska DL; Millar JC; Kodati B; Behera S; Chaphalkar RM; Nguyen T; Nguyen KT; Krishnamoorthy RR; Ellis DZ; Acharya S
    Mol Vis; 2021; 27():37-49. PubMed ID: 33633438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.